Miami Valves 2023: 30% Off for SOLACI Members

On February 2-4, 2023, Miami Valves 2023 will be held in Miami, Florida, USA. This is an international event featuring expert guests from around the world, with a highly educational scientific program on transcatheter therapies and valvular and structural heart disease.

SOLACI provides institutional support to the Congress and, as such, we are offering an exclusive 30% discount on registration fees for our members.

30% off in registration fees for SOLACI members!

To access this benefit, write to webservices@solaci.org and jornadas@solaci.org with the subject “I want the discount for Miami Valves 2023”. In the body of the email you must include your Name, Surname, Nationality and Email. Once we certify your membership status, the discount code with which you can register for the event will be shared.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOL SOLACI performed a new procedure in Argentina using bioabsorbable stents in pulmonary branches

The SOLACI Solidarity Program carried out a new procedure on a patient from the region of Frías, in Santiago del Estero (Argentina), during October...

Venezuela 2025 Sessions | Young Interventional Cardiologists Contest

Call for Case Submissions LIII SOLACI Regional Sessions – 18th Andean Region We invite all young Latin American cardiologists to submit clinically relevant interventional cardiology cases...

See the Best Moments from the Costa Rica 2025 Sessions

Relive the most remarkable highlights of the Costa Rica 2025 Sessions, held from October 8 to 10, 2025, at the Intercontinental Hotel in San...

Data Update Campaign for SOLACI Members. Let’s Stay Connected

Data Update for SOLACI Members. We aim to keep our members informed about all developments and matters related to the association. In this regard, we...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

CALIPSO: Calcified Lesions and Use of OCT

Percutaneous coronary intervention (PCI) in calcified lesions remains one of the most challenging scenarios in daily practice, as these lesions are often accompanied by...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...